MENU
RVP
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION

RVP stock forecast, quote, news & analysis

Retractable Technologies Inc is engaged in the manufacturing and marketing of safety medical products (predominantly syringes) for the healthcare industry... Show more

RVP
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for RVP with price predictions
Sep 25, 2026

RVP's Stochastic Oscillator stays in oversold zone for 1 day

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 25, 2026. You may want to consider a long position or call options on RVP as a result. In 67 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.

RVP moved above its 50-day moving average on September 25, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +5.78% 3-day Advance, the price is estimated to grow further. Considering data from situations where RVP advanced for three days, in 187 of 279 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.

RVP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 73 of 105 cases where RVP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 70%.

Bearish Trend Analysis

The 10-day RSI Indicator for RVP moved out of overbought territory on August 27, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 16 similar instances where the indicator moved out of overbought territory. In 13 of the 16 cases, the stock moved lower in the following days. This puts the odds of a move lower at 81%.

The Moving Average Convergence Divergence Histogram (MACD) for RVP turned negative on September 03, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 31 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 74%.

The 10-day moving average for RVP crossed bearishly below the 50-day moving average on September 23, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 75%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RVP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 5 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 38 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.288) is normal, around the industry mean (5.017). P/E Ratio (8.130) is within average values for comparable stocks, (163.659). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (4.450). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (0.600) is also within normal values, averaging (56.074).

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating fairly steady price growth. RVP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RVP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Intuitive Surgical (NASDAQ:ISRG), Align Technology (NASDAQ:ALGN).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 8.74B. The market cap for tickers in the group ranges from 126 to 141.14B. ISRG holds the highest valuation in this group at 141.14B. The lowest valued company is HGYMF at 126.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was 1%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was 20%. NNNN experienced the highest price growth at 20%, while NXGL experienced the biggest fall at -35%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was -55%. For the same stocks of the Industry, the average monthly volume growth was 29% and the average quarterly volume growth was -9%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 58
Price Growth Rating: 52
SMR Rating: 81
Profit Risk Rating: 95
Seasonality Score: -41 (-100 ... +100)
View a ticker or compare two or three
RVP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a developer of safety needle devices for the healthcare industry

Industry PharmaceuticalsOther

Industry
Medical Specialties
Address
511 Lobo Lane
Phone
+1 972 294-1010
Employees
201
Web
https://www.retractable.com
RVP's Stochastic Oscillator stays in oversold zone for 1 day